BIT's 12th Annual World Cancer Congress-2019(WCC-2019)
★ Scientific Program

Preliminary Program

 

Session times on those days will not be finalized until the overall program schedule is completed.

Program Tracks (Please click each Track for detailed program information)

Opening Ceremony and Keynote Forum

Track 1: Recent Advances in Cancer Research

Track 2: Breakthroughs in Cancer Prognostics and Diagnostics

Track 3: Best Practice on Clinical Oncology

Track 4: Clinical Research

Track 5: Novel Approaches to Cancer Therapeutics

 

Track 1: Recent Advances in Cancer Research

Track 1-1: Cancer Molecular Biology

Time: May 15, 2019 (Wednesday)
Place: Heian South, 4th Floor

Chair

Dr. Ying Chen, Professor, Chengdu Women's and Children's Central Hospital, Chin

13:30-13:35

Chair's Introduction

13:35-13:55

Title: Development of an Orally-Administered Peptide Vaccine against KRAS Positive Cancers Using a Double-Coated Live Delivery Vector Approach
Dr. Lionel L. A. In, Deputy Dean, UCSI University, Malaysia

13:55-14:15

Title: Association of Familial Hodgkin Lymphoma with Deficiency of Adenosine Deaminase 2 (DADA2)
Dr. Ghaleb Elyamany, Hematopathology Consultant, Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Saudi Arabia

14:15-14:35

Title: Identification and Characterization of Novel Tumor Cell Cycle Regulators Using shRNA Expression Vector Library
Dr. Vivi Kasim, Associate Professor, Chongqing University, China

14:35-14:55 Title: MiRNA Pain of Endometriosis
Dr. Ying Chen, Professor, Chengdu Women's and Children's Central Hospital, China
14:55-15:15 Title: IL-33 Promotes Tumor Growth and Metastasis by Remodeling the Tumor Microenvironment
Dr. Maria Marjorette O. Pena, Associate Professor & Director, Mouse Experimentation Core - Center for Colon Cancer Research, University of South Carolina, USA

15:15-15:30

Coffee Break

15:30-15:50 Title: Anesthesia and Cancer Metastasis
Dr. Rick Sai-Chuen Wu, Professor, China Medical University, Taiwan
15:50-16:10

Title: Down-Regulation of A20 in the Tumor Microenvironment Suppresses Tumor Growth by Inducing MDSC Apoptosis and Blocking Protumor Macrophage Polarization
Dr. Bin Shao, Associate Professor, State Key Laborary of Oral Diseases West China Hospital of Stomatology, Sichuan University, China

16:10-16:30

Title: Cytotoxic Anticancer Activity of Graphene Oxide-Associated Therapeutic Antibodies
Dr. Xinjian Chen, Associate Professor, University of Utah School of Medicine, USA

16:30-16:50

Title: Saponin from Tupistra Chinensis Bak Inhibits NF-κB Signaling in Sarcoma S-180 Cell Mouse Xenografts
Dr. Yingwen Zhang, Professor, Department of Integrated Traditional and Western Medicine, Zhongnan Hospital of Wuhan University, China

 

Track 1-2: Cancer Cell Biology

Time: May 16, 2019 (Thursday)
Place: Takasago, 4th Floor

Chair

Dr. Adolfo Cavalié, Professor, Experimental and Clinical Pharmacology and Toxicology, Saarland University, Germany

Co-Chair Dr. Sen-Yung Hsieh, Professor & Chair, Chang Gung Memorial Hospital, Taiwan

09:00-09:05

Chair's Introduction

09:05-09:25

Title: Feedback Control of the Estrogen-Chemokine Axis in Reproductive Cancers
Dr. André Tremblay, Full Professor, University of Montreal, Canada

09:25-09:45

Title: Sec61-Mediated Calcium Depletion in The Endoplasmic Reticulum of Cancer Cells
Dr. Adolfo Cavalié, Professor, Experimental and Clinical Pharmacology and Toxicology, Saarland University, Germany

09:45-10:05

Title: RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis in vivo
Dr. Qiao Hu, Associate Chief Physician, The People’s Hospital of Guangxi Zhuang Autonomous Region, China

10:05-10:25

Title: Molecular Basis of Anti-Cancer Effect of Huaier and Specific Influence to the Natural Selection of iPS Cells and Stable Growth in vivo
Dr. Tomoo Tanaka, President, Bradeion Institute of Medical Sciences, Co. Ltd., Japan

10:25-10:45

Title: Turtle Shell Inhibits Angiogenesis by Down-Regulating Glycolysis/Gluconeogenesis Signaling in Zebrafish
Dr. Xiang Tu, Assistant Professor, Teaching Hospital of Chengdu University of Traditional Chinese Medicine, China

10:45-11:00

Coffee Break

11:00-11:20

Title: Actin Cytoskeleton Remodeling-Induced Epithelial-Mesenchymal Transition: A Mechanistic Link of Large Tumors with Invasion/Metastasis
Dr. Sen-Yung Hsieh, Professor & Chair, Chang Gung Memorial Hospital, Taiwan

11:20-11:40

Title: Tumour-Suppressive and Tumour-Promoting Functions of Activin Signaling in Melanoma
Dr. Daniel B. Constam, Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland

11:40-12:00

Title: The Short and Long Term Efficacy and Safety of Completely Anatomic Thoracoscopic Segmentectomy in the Treatment of Solitary Pulmonary Nodules
Dr. Guiping Yu, Associate Chief Physician, The Affiliated Jiangyin Hospital of Southeast University Medical College, China

12:00-12:20

Title: From Autophagy to Autosis - Reprogramming of Cancer Cell Metabolism, as a Tool for Tumor Eradication
Dr. Kaja Urbanska, Assistant Professor, Warsaw University of Life Sciences - SGGW, Poland

 

Hosting Organization

BIT Group Global Ltd.

Supporting Organization
Cooperation Organization

Japan-China Business Co., Ltd.

日中商務株式会社

International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2008-2019 BIT Congress Inc.